Background. Although (general practitioners) GPs have a role in managing patients with advanced cancer, little is known about their referral decisions. Aim. The aim of this study was to explore, using structured vignettes, how GPs might manage patients presenting with advanced cancer. Design. A self-administered survey consisting of structured vignettes was administered to GPs in Australia. Fifty-six vignettes describing patients who may benefit from palliative care and/or treatment were constructed encompassing seven advanced cancer diagnoses (cerebral metastasis, lung metastases, renal cancer, bone metastases, ulcerating skin metastases, spinal metastases and stridor) and three clinical variables (age, prognosis and mobility). Seven vignettes were presented to each respondent. Respondents were asked if they would refer the patient and the benefits of different treatment modalities. Participant responses were compared with responses provided by an expert panel. Logistic regression and parametric tests were used to estimate odds of referral. Setting/Participants. The respondents were GPs, currently registered and practicing in Australia. Participants were selected randomly from a national list of practitioners. Results. Four hundred and seven questionnaires were received. There was wide variation (31%-97%) in the proportion of respondents who agreed with the expert panel. The odds of referral for radiotherapy varied the most. Significant predictive variables included patient age, mobility and prognosis and respondent demographics. Conclusion. GPs' referral decisions for patients with advanced cancer appear to deviate from expert opinion and can be predicted using respondent and patient characteristics. If these data were reflected in clinical practice some patients may not be offered helpful palliative treatment options.
Introduction
The role of GPs (family doctors) in managing advanced cancer patients varies (1) . Because GPs are often the first point of contact for patients when they are unwell or experiencing new symptoms that may be cancer related, it is essential that they are able to assess patients and refer them in a timely and appropriate manner (2, 3) . Urgent referral is often required for patients who have advanced cancer symptoms to alleviate symptoms and improve quality of life. Treatment options for patients with advanced cancer may include surgery, chemotherapy, radiotherapy and different medications. Patients are also likely to benefit from referral to a palliative care service who are familiar with managing cancer symptoms and can provide ongoing care. In Australia the GP, as the gatekeeper to specialist services, will refer patients who present with what is suspected to be metastatic cancer to an oncology specialist or palliative care service. They may also continue to be involved in the patients' management until the end of life.
Unfortunately, radiotherapy is often overlooked as a treatment option for patients with advanced cancer and patients are referred for less effective treatments (4) . Radiotherapy will only be utilized appropriately if referring clinicians are aware of its value and referral is timely (5) . Delay in referral for radiotherapy is not uncommon and occurs for these reasons: diagnostic uncertainty, treatment not prioritized, patient related, access to treatment and other reasons (6, 7) . Level I evidence demonstrates that delays in treatment lead to poorer treatment outcomes, failure to relieve distressing symptoms and an increase in psychological distress experienced by patients (7, 8) .
Previous studies have found that GPs have varying knowledge of the use of radiotherapy and are therefore inhibited from appropriate referral (9) (10) (11) (12) . Chapman et al. (13) surveyed 374 rural Australian GPs about their involvement in cancer care and general knowledge of radiation therapy. Approximately 77% of GPs reported that they had insufficient knowledge to support their patient through radiation therapy. Samant et al. (12) surveyed 172 Canadian GPs about their knowledge of radiotherapy to find that:
• <40% of GPs stated that radiotherapy is effective in treating cerebral metastases, spinal cord compressions and haemoptysis • <55% of GPs believed that radiotherapy was 'very effective ' in the treatment of bone and soft tissue metastases (12) .
Factors that affected referral included uncertainty about benefits, life expectancy, location of practice and whether the GP had previously referred patients for radiotherapy. A subsequent study was conducted in Canada by Berrang and Samant (14) to similarly find that GPs lacked knowledge of effective management of haemopytsis and cerebral metastases in particular. Vulto et al. (14) adapted the same survey and administered it to GPs in the Netherlands to find that GPs had moderate to poor knowledge of how to manage painful local processes, cerebral metastases, airway obstruction, haemoptysis and haematuria.
The primary aim of this study was to explore how a variety of clinical and demographic variables impact on the likelihood of GPs referring/urgently referring advanced cancer patients for palliative treatment. A secondary aim was to calculate the impact of those variables on assessing the benefit of surgery, chemotherapy and radiotherapy. This study adopted an approach consistent with Clinical Judgement Analysis because it provides a quantitative method of determining the clinical judgements of GPs and identifying significant differences in their assessments of cases and treatment benefits (16) . Structured vignettes were presented to assess the GPs clinical judgment. Vignettes were used because they allowed the comparison of different respondents' behaviour over the same set of cases, and determination of potential independent effects of specific information on a person's judgments (17, 18) . We have previously used structured vignettes to explore decision making with health professionals (17, 19) .
Methods

Setting and Recruitment
The respondents were GPs, currently registered and practicing in Australia. Participants were selected randomly from a national list of practitioners registered on the AMPCO® GP database. One reminder was sent. Respondents received a gift voucher for their participation.
Survey design
A self-administered postal survey was undertaken. Vignettes (short stories) were developed about patients who had advanced cancer. Seven basic cases were designed to portray different advanced cancer situations that were potentially suitable for palliative treatment (surgery, chemotherapy and/or radiotherapy) (see Box 1) .
The 'research-to-practice pipeline' was used to frame GPs responses to structured vignettes (20) . This framework offers an understanding of the decision-making process and proposes that GPs proceed through four stages from evidence to actioning recommendations: awareness of evidence, agreement with it, adoption of it and finally adherence to it (20) . This study focused on GPs awareness of the benefit of different treatment options.
The cases and variables were selected after review of the literature and input from a team of experts (GPs, Palliative Care specialists and radiation oncologists). Similar to previous study (12, 14, 15 ) the focus of the scenarios was on the following seven cancer-related symptoms: painful bony metastases; spinal cord compression; haemoptysis; haematuria; painful local disease; cerebral metastases and airway obstruction. However, rather than asking GPs about how effective they consider radiotherapy; we instead presented them vignettes about each of the scenarios to determine whether they felt the patient would benefit from surgery; chemotherapy and/or radiotherapy.
Each case contained three patient-related variables and for each variable there were two possible variations: (i) Age (45 or 75 years) (ii) Mobility (good or poor) (iii) Prognosis (four or 16 weeks) Therefore, for each case there were eight scenarios to cover each of the possible combinations, producing a total of 56 scenarios (17) . Each scenario was presented as a short story and styled as demonstrated in Box 1.
The questionnaire was piloted and refined following feedback from 11 volunteer GPs.
An expert team containing a palliative care specialist, two radiation oncologists and two GPs were asked to review all 56 scenarios to produce 'expert' consensus about referral and the potential benefits for each treatment modality for each scenario. The expert panels' consensus for each diagnoses is presented in Box 1.
The vignettes were presented to the sample in an incompletewithin-blocks design so that each respondent received a different and random set of seven vignettes, including one scenario with each diagnosis. For each scenario the respondents were asked:
• whether they would refer the patient for palliative treatment; • whether they thought that any of the following forms of palliative treatment would be beneficial: surgery, chemotherapy, radiotherapy or medication; and • if they considered the case urgent Participants were also asked what medications they would prescribe. However, these results are not reported in this paper.
The respondents' demographic and workplace details were collected, including gender, age, location of practice, number of years in practice, weekly patient numbers (for both the practice and individual), number of full time GPs employed at the practice, involvement and experience in palliative care and number of cancer patients diagnosed per year.
Statistical analysis
Binary logistic regression was used to examine the odds of agreeing with the expert panel in relation to the following outcomes: the odds of referring a patient for palliative treatment, the odds of recommending an urgent referral, and odds of agreeing with the expert panel about the benefit of each of the following treatments: surgery, chemotherapy and radiotherapy.
Backward logistic regression was performed, and by comparing with a full model which includes all potential confounders, the simplest model was reported. Likelihood ratio tests were used to exclude variables not associated with the dependent variable and test for plausible interaction terms. All models had forced inclusion of the three specific clinical variables on vignette (age, mobility and estimated prognosis time). A threeway interaction between the three patient features was found to be insignificant during the modeling process, indicating that the certain combinations of features are not a stronger trigger for referral.
The final regression model was adjusted for the lack of independence between individual GP responses by estimating the clustered robust standard errors to account for intragroup correlation.
For logistic regression, due to the collapse or colinearity of some variables in the exploring models, the number of full-time GPs was regrouped into four groups (0-1, 2-4, 5-7 and >8); involvement in palliative care was regrouped into three groups (specialist, occasional, rarely/never); experience in palliative care was regrouped into two groups (postgraduate/other formal training/CME course versus Nil). Age of respondents and the number of cancer patients diagnosed per year were treated as ordinal variables in the regression.
Ordered logistic regression was used to assess the respondents' belief in which kind of therapy would benefit these patients. The outcome variables were the likeness of benefit from the treatment, and independent variables were the three patient features of the vignette. The intragroup correlation by individual respondents was adjusted by clustered robust standard errors in the model.
Cross-tabulations showing the patterns of agreement between GPs and the expert panel by various diagnoses are also presented. Chi-square test were performed where indicated. Statistical analysis was performed using Stata Statistical Software (IC 11.1, College Station, TX). 
Expert opinion
Refer urgently for all versions of this scenario. This patient is unlikely to benefit from surgery and chemotherapy.
Radiotherapy is likely to be beneficial for patients except when patients present with a poor prognosis of 4 weeks plus poor mobility or a poor prognosis and 75 years old.
Case 2
A '75 year old' patient presents with advanced cancer. He has 'good mobility'. His cancer has not responded to systemic
Results
Three thousand respondents were invited to participate. Ten percent of respondents were not at the stated address and/or not currently practicing as a general practitioner. A total of 407/2700 (15%) GPs responded.
A total of 407 participants returned the questionnaire and each of the participants assessed a set of 7 vignettes, thus the total number of vignettes was 2849. Eighty six He cannot afford private health care.
Expert opinion
Refer urgently for all version of this scenario. This patient is unlikely to benefit from surgery or chemotherapy. However, radiotherapy is likely to be beneficial for versions of this scenario.
Case 3
A '75 year old' patient presents with advanced cancer. He has 'good mobility'. His cancer has not responded to systemic treatment. 'He has metastatic renal cancer with haematuria.' His symptoms have improved slightly with medication prescribed. His surgeon estimates a prognosis of 'sixteen weeks'. He cannot afford private health care.
Expert opinion
Refer urgently for all version of this scenario. The patient is unlikely to benefit from surgery or chemotherapy except the patient who is 45, has good mobility and a prognosis of 16 weeks is likely to benefit from surgery. The patient is likely to benefit from radiotherapy unless they have a prognosis of 4 weeks plus poor mobility or a poor prognosis and 75 years old.
Case 4
A '75 year old' patient presents with advanced cancer. He has 'poor mobility'. His cancer has not responded to systemic treatment. 'He has pain in his left hip', suggesting bony metastases.' His symptoms have improved slightly with medication prescribed. His surgeon estimates a prognosis of 'sixteen weeks'. He cannot afford private health care.
Expert opinion
Refer urgently for all version of this scenario. This patient is unlikely to benefit from surgery or chemotherapy. However, radiotherapy is likely to be beneficial for all versions of this scenario.
Case 5
A '45 year old' patient presents with advanced cancer.
He has 'poor mobility'. His cancer has not responded to systemic treatment. 'He has pain from an ulcerating dermatological metastasis.' His symptoms have improved slightly with medication prescribed. His surgeon estimates a prognosis of 'four weeks'. He cannot afford private health care.
Expert opinion
Refer urgently for all version of this scenario. The patient is unlikely to benefit from surgery unless they have a prognosis of 16 weeks. The patient is unlikely to benefit from chemotherapy. The patient is most likely to benefit from radiotherapy if they have good mobility and a prognosis of 16 weeks.
Case 6
A '75 year old' patient presents with advanced cancer. He has 'good mobility'. His cancer has not responded to systemic treatment. 'He has back pain. X-rays suggest spinal metastasis in his lumbar spine.' His symptoms have improved slightly with medication prescribed. His surgeon estimates a prognosis of 'sixteen weeks'. He cannot afford private health care.
Expert opinion
Refer urgently for all versions of this scenario. The patient is unlikely to benefit from surgery and chemotherapy. The patient is likely to benefit from radiotherapy except when they are 75, have poor mobility and a prognosis of 4 weeks.
Case 7
A '75 year old' patient presents with advanced cancer. He has 'good mobility'. His cancer has not responded to systemic treatment. 'He has stridor from upper respiratory obstruction.' His symptoms have improved slightly with medication prescribed. His surgeon estimates a prognosis of 'four weeks'. He cannot afford private health care.
Expert opinion
Refer urgently for all versions of this scenario. The patient is unlikely to benefit from surgery unless they are 45, have good mobility and a prognosis of 16 weeks. The patient is unlikely to benefit from chemotherapy. The patient is likely to benefit from radiotherapy unless they have a poor prognosis of 4 weeks.
vignettes were missing the primary outcome question 'Would you refer this patient for palliative treatment?' and were excluded from analysis resulting in a total of 2762 vignettes in the analysis.
Demographics Table 1 provides a summary of participant demographics. There were a similar number of male and female respondents. More than half of respondents were aged 50 years and older (57%). More than half of the GPs were from a metropolitan or outer metropolitan area (69%), had 21 years or more experience (54%) and saw 101-200 patients per week (52%). Fiftythree percent of participants reported that they consult 1-5 cancer patients per year. Seventy-seven percent of participants reported that they only see palliative patients' occasionally, 13.5% reported that they rarely consult palliative patients and 3% reported that they never consult palliative patients. Sixtyseven percent of participants reported that they have completed CME courses/informal training on palliative care, while 23% had completed no palliative care training.
Main findings
GPs agreement with the expert panel varied depending on the patient diagnoses and each of the analyses variables: refer, refer urgently, benefit from surgery, benefit from chemotherapy and benefit from radiotherapy ( Table 2) . Overall agreement in relation to referral was high (88%-96%). Agreement for urgent referral ranged from 81%-97%. Agreement for benefit of surgery ranged from 53%-97%. Agreement for benefit of chemotherapy ranged from 81%-90%. The largest discrepancy was in relation to agreement for benefit of radiotherapy which ranged from 31%-80%.
An overall analysis was conducted to determine which variables impacted overall on referral for all diagnoses ( Percentage may not total 100 due to rounding errors. experience in palliative care. GPs with 21 or more years of practice were significantly less likely to agree with the expert panel regarding the need for referral. GPs with palliative care training were significantly more likely to agree with expert regarding referral compared with GPs who had no palliative care training.
Odds of referring and referring urgently
Analysis was then conducted to determine the odds of GPs agreeing with the expert panel for each scenario for each of the following management options: referral; urgent referral; benefit of surgery; benefit of chemotherapy and benefit of radiotherapy. Training in palliative care significantly increased the odds of referring in line with expert opinion for the following diagnoses (Table 4) : Bony metastases (odds ratio; OR = 2.78), ulcerating skin lesions (OR = 2.32), spine metastases (OR = 8. 21) and stridor (OR = 3.83). Training and experience did not significantly impact on the odds of referral for cerebral metastasis, lung metastases and renal cancer. Training in palliative care also significantly increased the odds of referring urgently in line with the expert panel for spine metastases (OR = 2.45) ( Table 4) .
The clinical variables (age, mobility and prognosis) did not significantly impact on agreement on referral except mobility for patients presenting with bony metastases (OR = 3.24) and ulcerating skin (OR = 2.57). These results are presented in Table 4 .
GPs who consulted more than 201 patients per week were less likely to agree with expert on providing urgent referral when required for the following diagnoses: renal cancer (OR = 0.22); bony metastases (OR = 0.15); ulcerating skin (OR = 0.16); and spine metastases (OR = 0.15) (see Table 4 for details). The number of patients GPs consulted did not impact on the odds of referring urgently for cerebral metastasis, lung metastases and stridor.
Patient age and mobility did not impact on the agreement for urgent referral for any of the cases. However, patient prognosis did impact on the odds of agreeing with the expert panel about referring urgently for renal cancer (OR = 1.94) and bony metastases (OR = 8.82). These results are presented in Table 4 .
As Table 4 demonstrates, other GP demographics (e.g. gender of GP, age of GP) also had an impact on the odds of referring and referring urgently in line with the expert panel, but not consistently.
Referring for different treatment options
Clinical variables exerted a significant role on the odds of agreement with the expert panel on the benefits of each treatment option.
For example, poor mobility increased the odds of agreement with the expert panel about whether surgery would be beneficial Table 5 . For chemotherapy clinical variables had less of an impact as to whether participants agreed with the expert panel about whether chemotherapy would be beneficial. Poor mobility increased the odds of agreement with the expert panel about identifying whether chemotherapy would be beneficial for renal cancer (OR = 1.81). Poor prognosis had significant odds ratios for lung metastases (OR = 2.90), renal cancer (OR = 2.12) and stridor (OR = 2.14). Interestingly, years in practice (21+ years) increased the odds of agreeing with the expert panel about whether chemotherapy would be beneficial for cerebral metastasis (OR = 2.71), bony metastases (OR = 1.57) and ulcerating skin lesions (OR = 3.53). These results are presented in Table 5 .
Patient variables also played a significant role in whether participants agreed with the expert panel about the benefit of radiotherapy for five out of seven diagnosis. For lung metastases and stridor there were no clinical variables that were significant. Unlike surgery and chemotherapy, the odds of agreement with the expert panel about the benefit of radiotherapy were decreased when the patients presented with poor mobility, poor prognosis and aged 75 years for the following diagnoses: cerebral metastasis, bony metastases, ulcerating skin and spinal metastases. Poor mobility decreased the odds of agreement with the expert panel about the benefit of radiotherapy for bony metastases (OR = 0.56) and spinal metastasis (OR = 0.35). Poor prognosis also decreased the odds of agreement with the expert panel about the benefit of radiotherapy for participants with cerebral metastasis (OR = 0.5), and spinal metastases (OR = 0.36). Age (75 years) decreased the odds of agreement with the expert panel about the benefit of radiotherapy for cerebral metastases (OR = 0.6), ulcerating malignant skin lesion (OR = 0.62) and spine metastases (OR = 0.49). For metastatic renal cancer GP participants were more likely to agree with the expert panel about the benefit from radiotherapy for patients presenting with poor mobility (OR = 2.49), poor prognosis (OR = 5.07) and 75 years of age (OR = 1.64). These results are presented in Table 5 .
Several demographic variables also impacted on whether GPs agreed with the expert panel about benefit of radiotherapy. For example, females were less likely to agree with the expert panel for lung metastases (OR = 0.53) and ulcerating skin lesions (OR = 0.61). The number of patients GPs saw per week increased the odds of agreement with the expert panel about benefit of radiotherapy for renal cancer and bony metastases. Years in practice increased the odds of agreement with the expert panel about benefit of radiotherapy for cerebral metastases.
Discussion
Most GP respondents in this study were likely to refer patients presenting with advanced cancer for palliative treatment. GPs often chose to refer urgently (81%-97%), which was consistent with the views of the expert panel. GP-related factors that impacted on overall referral included years in practice and training or experience in palliative care.
The experts advised that for many of the cases radiotherapy would be the preferred choice of treatment. From our data it is evident that although Australian GPs are aware of the need to refer/refer urgently and the benefits of surgery and chemotherapy in this context they may not refer for radiotherapy for some advanced cancer diagnoses. Agreement with the expert panel on the benefits of treatment options varied the most for radiotherapy (31%-80%). This finding is consistent with previous studies (12, 14, 15) .
The odds of agreement with the expert panel about the benefits of different treatment options for the diagnoses presented varied according to patient factors (age, mobility and prognosis) and GP demographics. For surgery and chemotherapy the odds of referring as per expert panel increased for some diagnoses when patients presented at 75 years of age and/or had poor mobility and/or a poor prognosis. However, these same patient factors for some diagnoses (cerebral metastases, bony metastases, ulcerating malignant skin lesions and spinal metastases) decreased the odds of agreement with the expert panel for radiotherapy.
Samant et al. (12) reported that factors that affected referral for radiotherapy included uncertainty about benefits, life expectancy, location of practice and whether the GP had previously referred patients for radiotherapy. With respect to radiotherapy the odds of agreement with the expert panel in this study decreased for some diagnoses for patients at 75 years of age,poor mobility and/or a poor prognosis. GP-related factors such as gender, patients seen per week, years in practice and experience in palliative care also impacted on the odds of referring consistently with the expert panel for radiotherapy.
It is recommended that 52% of all cancer patients receive radiotherapy at some stage during their cancer diagnoses (21, 22) . In Australia, 34%-38% of all cancer patients receive radiotherapy. Recent estimates suggest that 14% of all new cancer cases should optimally receive palliative radiotherapy; however, there is currently no estimate for the number of courses for all palliative radiotherapy (radiotherapy for new cancer and subsequent relapses) (23) . Access to radiotherapy is limited in Australia and delays may occur. In 2002 more than 15 000 patients who would have benefited from radiotherapy were not able to access radiotherapy (21) . Furthermore, Kenny and Lehman found that 29% of patients who were referred for palliative radiotherapy for the relief of pain or other disabling symptoms had to wait longer than 2 weeks before treatment was started (7) . Additionally 13% of patients referred for urgent radiotherapy experienced delays beyond 48 hours (7). Morgan et al. (24) reported that failure to treat patients and delays in radiotherapy are occurring because there is a 'GAP' in radiotherapy services in terms of availability of linear accelerators and staff.
From these data some GPs may not refer for radiotherapy for advanced cancer diagnoses. This may be because radiotherapy has not always been readily available and has previously been reported to not meet the needs of Australians diagnosed with cancer (21, 22) . GPs referral for radiotherapy may increase if the benefits of radiotherapy are emphasised and access to treatment is more readily available.
Limitations
A significant challenge in postal surveys is a modest response rate. We recorded a similar response rate (15%) to other published GP postal surveys in Australia (25) . More respondents were female and or had 20 years or more experience relative to the national profile of GPs (26) . We acknowledge that although the vignettes presented some clinical data about the cases, they did not include all possible explanatory variables. The expert panel had five members (two GPs, two radiation oncologists and one palliative care specialist) and recommendations about the benefit of palliative treatment options may vary. These experts were chosen because of the focus on referrals for radiation oncology. It may have also been of value to include a medical oncologist, to offer a perspective on other treatment modalities. There are no national guidelines on referral of advanced cancer patients for palliative treatment and therefore the project relied on the deliberations of an expert panel for guidance on the clinical issues.
Conclusion
GPs' referral decisions and assessment of treatment benefits for patients with advanced cancer appear to deviate from expert opinion and can be predicted on a range of respondent and patient characteristics. If these data were reflected in clinical practice some patients may not be offered helpful palliative treatment. In practice more patients with advanced cancer may benefit from radiotherapy if referred. The reasons for these findings mandate future research. Table 5 . Continued
